<DOC>
	<DOCNO>NCT02946489</DOCNO>
	<brief_summary>Cannabis use disorder remain significant public health problem . The pharmacological facilitation behavioral treatment represent promise strategy address disorder cannabis use . Cannabis use disorder recognize associate various vulnerability complicate course treatment may amenable glutamate modulators . The purpose randomized , double-blind , controlled trial test various glutamate modulators conjunction motivational enhancement therapy ( MET ) mindfulness base relapse prevention ( MBRP ) cannabis use disorder .</brief_summary>
	<brief_title>Facilitating Behavioral Treatment Cannabis Use Disorder</brief_title>
	<detailed_description>Individuals diagnose cannabis dependence randomize receive one two infusion glutamate modulators week 2 week 3 4 . The participant also receive 2-week course MET 4-week course MBRP . Participants meet staff twice weekly , except week 2 potentially week 3 4 participant present clinic three time . Clinic visit include MET session , MBRP session , psychiatric monitoring , assessment , study procedure ( e.g. , medication administration ) .</detailed_description>
	<mesh_term>Marijuana Abuse</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>Meets DSMIV criterion cannabis dependence , least 5 day use per week past 30 day display least one positive utox screen Physically healthy No adverse reaction study medication 2160 year age Capacity consent comply study procedure Seeking treatment Meets DSM IV criterion current major depression , bipolar disorder , schizophrenia , psychotic illness , include substanceinduced psychosis , current substanceinduced mood disorder . Physiological dependence another substance require medical management , alcohol , opioids , benzodiazepine , exclude caffeine , nicotine . Pregnant , interested become pregnant , lactate Delirium , Dementia , Amnesia , Cognitive Disorders , dissociative disorder Current suicide risk history suicide attempt within past 2 year On psychotropic medication whose effect could disrupt participation study Recent history significant violence ( past 2 year ) . Heart disease indicate history , abnormal ECG , previous cardiac surgery . Unstable physical disorder might make participation hazardous endstage AIDS , hypertension ( &gt; 140/90 ) , anemia , pulmonary disease , active hepatitis liver disease ( transaminase level &lt; 23 X upper limit normal consider acceptable ) , untreated diabetes Previous history misuse study medication BMI &gt; 35 , history undocumented obstructive sleep apnea First degree relative psychotic disorder ( bipolar disorder psychotic feature , schizophrenia , schizoaffective disorder , psychosis NOS )</criteria>
	<gender>All</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>cannabis</keyword>
	<keyword>mindfulness base relapse prevention</keyword>
	<keyword>motivational enhancement therapy</keyword>
</DOC>